Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

428.59 -1.34 (-0.31%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 935,892
Open 429.07
Bid (Size) 428.05 (1)
Ask (Size) 431.38 (2)
Prev. Close 429.93
Today's Range 422.44 - 429.93
52wk Range 335.82 - 448.40
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating
On Tuesday, Catalyst Pharmaceuticals stock hit a key technical milestone, with its Relative Strength Rating climbing to 83 from 79. 
Via Investor's Business Daily
3 Cheap Biotech Stocks to Buy Now: May 2024
Many of these cheap biotech stocks are on their way to achieving FDA approval for their drugs to enter the market. 
Via InvestorPlace
Exposures Product Safety

Performance

YTD
+4.30%
+4.30%
1 Month
+7.86%
+7.86%
3 Month
+2.40%
+2.40%
6 Month
+13.11%
+13.11%
1 Year
+22.75%
+22.75%

More News

Read More
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
Via Benzinga
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy
Via The Motley Fool
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
Via The Motley Fool
Stock Market Moves Toward Highs; Arista, Toast, Palantir Key Earnings Movers: Weekly Review
Via Investor's Business Daily
Will the Biotech Sector Shift From Lagger to Leader?
Via MarketBeat
Topics ETFs
A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics
Via Benzinga
Investors seeking growth at a reasonable cost should explore NASDAQ:VRTX.
Via Chartmill
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
Markets In A Minute - "A Lack Of Further Progress"
Via Talk Markets
Topics Economy Workforce
Exposures Interest Rates Layoff
Smart Money Is Betting Big In VRTX Options
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
US Stocks Eye Fourth Positive Session Despite Hawkish Fed Remarks; Disney, Palantir Tumble; Treasury Yields Fall: What's Driving Markets Tuesday?
Via Benzinga
Topics Economy
Exposures Interest Rates
VRTX Stock Earnings: Vertex Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Vertex Beats First-Quarter Expectations, But Shares Stay Flat On Reiterated Outlook
Via Investor's Business Daily
Vertex Reports First Quarter 2024 Financial Results
From Vertex Pharmaceuticals Incorporated
Via Business Wire
3 Biotech Stocks to Double Your Money in the Next 24 Months
Via InvestorPlace
3 No-Brainer Stocks to Buy in May
Via The Motley Fool
3 Biotech Stocks With the Potential to Make You an Overnight Millionaire
Via InvestorPlace
Exposures Product Safety
A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
Via Investor's Business Daily
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar
Via InvestorPlace
3 Growth Stocks You’ll Kick Yourself for Not Buying Today
Via InvestorPlace
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.